eleven patients with chronic ventricular arrhythmias took part in a study of n-acetylprocainamide ( napa ) , the major metabolite of procainamide , in order to characterize further napa 's clinical pharmacology and antiarrhythmic action .
C0033216
procainamide
C0003195
antiarrhythmic